Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction

Gynecological Endocrinology

Volumn 20, Issue 4, 2005, Pages 188-194

  Manna, Claudio ^a,b   Rahman, A ^b,e   Sbracia, M ^b   Pappalardo, S ^b   Mohamed, E I ^c,d   Linder, R ^d   Nardo, L G ^f  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b 'Genesis' Centre for Human Reproduction and Therapy of Infertility   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d ALEXANDRIA UNIVERSITY   (Egypt)

^e UNIVERSITY OF LÜBECK   (Germany)

^f KINGSTON HOSPITAL   (United Kingdom)

Author keywords

Controlled ovarian stimulation; Gonadotrophin releasing hormone analogue; Long term and short term pituitary desensitization; Luteinizing hormone

Indexed keywords

BUSERELIN; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADORELIN DERIVATIVE; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED OVARY STIMULATION; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION; FOLLITROPIN BLOOD LEVEL; HUMAN; HYPOPHYSIS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFERTILITY THERAPY; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OOCYTE; OVARY FOLLICLE; OVULATION INDUCTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSVAGINAL ECHOGRAPHY;

ADULT; AREA UNDER CURVE; BUSERELIN; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEINIZING HORMONE; MALE; OVULATION INDUCTION; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; TRIPTORELIN;

EID: 20844462389     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/09513590400027141     Document Type: Article

References (34)

1. MacLachlan V, Besanko M, O'Shea F, Wade H, Wood C, Trounson A, Healy DL. A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization. N Engl J Med 1989;320:1233-7.
2. Filicori M. Clinical review: Gonadotropin-releasing hormone analogs in ovulation induction: current status and perspectives. J Clin Endocrinol Metab 1996;81:2413-16.
3. Hillier SG. Gonadotropic control of ovarian follicular growth and development. Mol Cell Endocrinol 2001;179:39-46.
4. Creus M, Penarrubia J, Fabregues F, Vidal E, Carmona F, Casamitjana R, Vanrell JA, Balasch J. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod 2000;15:2341-6.
5. Filicori et al. (1999)
6. Kilani Z, Dakkak A, Ghunaim S, Cognigni GE, Tabarelli C, Parmegiani L, Filicori M. A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes. Hum Reprod 2003;18:1194-9.
7. Al Hasani S, Kupker W, Baschat AA, Sturm R, Bauer O, Diedrich C, Diedrich K. Mini-swim-up: a new technique of sperm preparation for intracytoplasmatic sperm injection. J Assist Reprod Genet 1995;12:428-33.
8. Scott LA, Smith S. The successful use of pronuclear embryo transfers the day following oocyte retrieval. Hum Reprod 1998;13:1003-13.
9. Yim SF, Lok IH, Cheung LP, Briton-Jones CM, Chiu TT, Haines CJ. Dose-finding study for the use of long-acting gonadotrophin-releasing hormone analogues prior to ovarian stimulation for IVF. Hum Reprod 2001;16:492-4.
10. Fleming R, Lloyd F, Herbert M, Fenwick J, Griffith T, Murdoch A. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone. Hum Reprod 1998;13:1788-92.
11. Strohmer H, Chatwani S, Wieser F, Danninger B, Obruca A, Feichtinger W. Prospective randomized study of an ultrashort gonadotrophin-releasing hormone agonist versus a modified suppression protocol for ovarian stimulation in intracytoplasmic sperm injection cycles. Hum Reprod 1997;12:1403-8.
12. Janssens RM, Vermeiden JP, Lambalk CB, Schats R, Schoemaker J. Gonadotrophin-releasing hormone agonist dose-dependency of pituitary desensitization during controlled ovarian hyperstimulation in IVF. Hum Reprod 1998;13:2386-91.
13. Daya S. Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles. Cochrane Database Syst Rev 2000;(2):CD001299.
14. Loumaye E, Van Krieken B, Depreester S, Psalti I, De Cooman S, Thomas K. Hormonal changes induced by short term administration of a gonadotrophin- releasing hormone agonist during ovarian hyperstimulation for in vitro fertilization and their consequences for embryo development. Fertil Steril 1989;51:105-11.
15. Tan SL, Kingsland C, Campbell S, Mills C, Bradfield J, Alexander N, Yovich J, Jacobs HS. The long protocol of administration of gonadotropin- releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization. Fertil Steril 1992;57:810-14.
16. Stanger JD, Yovich JL. Reduced in-vitro fertilization of human oocyte from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynaecol 1985;92:385-93.
17. Howles CM, MacNamee MC, Edwards RG, Goswamy R, Steptoe PC. Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation. Lancet 1986;i:521-2.
18. Chappel SC, Howles C. Re-evaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Hum Reprod 1991;6:1206-12.
19. Regan L, Owen EJ, Jacobs HS. Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet 1990;336:1141-4.
20. Homburg R, Annar NA, Eshel A, Adams J, Jacobs HS. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. Br Med J 1988;297:1024-6.
21. Tesarik J, Hazout A, Mendoza C. Luteinizing hormone affects uterine receptivity independently of ovarian function. Reprod Biomed Online 2003;7:59-64.
22. Overes HW, de Leeuw R, Kloosterboer HJ. Regulation of aromatase activity in FSH-primed rat granulosa cells in vitro by follicle-stimulating hormone and various amounts of human chorionic gonadotrophin. Hum Reprod 1992;7:191-6.
23. Yong EL, Baird DT, Yates R, Reichert LE Jr, Hillier SG. Hormonal regulation of the growth and steroidogenic function of human granulosa cells. J Clin Endocrinol Metab 1992;74:842-9.
24. Hillier SG. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod 1994;9:188-91.
25. Erickson GF, Magoffin DA, Dyer CA, Hofeditz C. The ovarian androgen producing cells: a review of structure-function relationships. Endocr Rev 1985;6:371-99.
26. Richards JS, Hickey GJ, Chen SA, Shively JE, Hall PF, Gaddy-Kurten D, Kurten R. Hormonal regulation of estradiol biosynthesis, aromatase activity, and aromatase mRNA in rat ovarian follicles and corpora lutea. Steroids 1987;50:393-409.
27. Gordon UD, Harrison RF, Fawzy M, Hennelly B, Gordon AC. A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome. Fertil Steril 2001;75:324-31.
28. Humaidan P, Bungum L, Bungum M, Andersen CY. Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation. Hum Reprod 2002;17:2016-21.
29. Westergaard LG, Laursen SB, Andersen CY. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum Reprod 2000;15:1003-8.
30. Tesarik J, Mendoza C. Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocytes donors on oocyte yield and developmental competence. Hum Reprod 2002;17:3129-37.
31. Hillier SG. Ovarian stimulation with recombinant gonadotropins: LH as an adjunct to FSH. In: Jacobs HS, editor. The new frontier in ovulation induction. Carnforth, UK: Parthenon Publishing; 1993. pp 39-47.
32. Esposito MA, Barnhart KT, Coutifaris C, Patrizio P. Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone. Fertil Steril 2001;75:519-24.
33. Jacobs RA, Oosterhuis J, Porter DG, Lobb DX, Yuzpc AA, Challis JR. Immunoreactive adrenocorticotrophin is present in the ovary and in particular the oocyte of several mammalian species. J Reprod Fertil 1991;91:285-91.
34. Rabe T, Diedrich K, Eberhardt I, Kupker W. In vitro fertilization. In: Rabe T, Diedrich K, Runnebaum B, editors. Manual on assisted reproduction. Berlin: Springer-Verlag; 1997. p 297.